Equities

Merit Medical Systems Inc

Merit Medical Systems Inc

Actions
  • Price (EUR)96.00
  • Today's Change2.00 / 2.13%
  • Shares traded54.00
  • 1 Year change+45.45%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:41 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5875868
Total Receivables, Net189178173
Total Inventory304266222
Prepaid expenses262620
Other current assets, total2.11----
Total current assets1,108529482
Property, plant & equipment, net447448438
Goodwill, net382360362
Intangibles, net326276319
Long term investments------
Note receivable - long term3.242.402.35
Other long term assets524239
Total assets2,3251,6641,648
LIABILITIES
Accounts payable666956
Accrued expenses132118135
Notes payable/short-term debt000
Current portion long-term debt/capital leases--118.44
Other current liabilities, total5.492337
Total current liabilities204221236
Total long term debt823187234
Total debt823198243
Deferred income tax5.551832
Minority interest------
Other liabilities, total9194106
Total liabilities1,123520608
SHAREHOLDERS EQUITY
Common stock638675642
Additional paid-in capital------
Retained earnings (accumulated deficit)575481406
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(11)(12)(7.99)
Total equity1,2021,1441,040
Total liabilities & shareholders' equity2,3251,6641,648
Total common shares outstanding585757
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.